TriLink BioTechnologies

How to Succeed in Personalized Medicine by Using Tools and Technologies

Print Email to a friend

Published January 2006

Pharmacogenomics is sparking a new molecular revolution that will have a considerable impact on drug development costs.

D&MD's How to Succeed in Personalized Medicine by Using Tools and Technologies market analysis report provides a clear understanding of the regulatory and commercial influences, elements shaping this growing market and offers an intensive investigation of pharmacogenomic business issues.


  • Definitively understand the rate of adoption of SNP Genotyping, DNA purification and other pharmacogenomic activities
  • Hear the results of ninety (90) interviews from CEO's, CSO's and VP of Regulatory Affairs of leading biotechnology companies and large pharma companies.
  • Learn the percent of companies with a drug influenced by pharmacogenomics, segmented by large pharma, large biotech, and medium biotech.
  • Learn the activities your largest competitiors are employing to successfully address the market questions of pharmacogenomic implementation.
  • Receive an update on FDA guidance and understand where expectations are for future guidance.
  • Understand the impact of COX-2 inhibitors (e.g. Vioxx, Bextra) on the need for personalized medicine.
  • The business models that are driving the adoption of personalized medicine.

Personalized medicine is now, not later. Buy this report to get the information you need to position your company for success.

Contents at a Glance:


  • Executive Summary
  • Companies Realizing the Pharmacogenomics

    • Market Opportunities
    • Requirements for Market Adoption in the Pharmaceutical Industry

  • Industry Forecast

    • Forms of Pharmacogenomics Success
    • Key Elements of the Pharmaceutical Value Chain

  • Regulatory Update

    • Current Regulatory Process for Drug Development
    • Key Issues Facing Industry
    • Issues Facing the FDA
    • Impact to Industry from Pharmacogenomics Regulation
    • Summary of FDA Guidance for Industry

  • Intellectual Property: Compelling Filings by Large and Emerging Players

    • Strategic Considerations & Implications of Patenting

  • Company Profiles

    • Affymetrix, Inc., DXS - Genotyping Services, Incyte Corporation, Sequenom, Inc

Single Copy Print $4,950.00
Single Copy PDF $4,950.00

Further Information: http://www.marketreports.com/x#1433.html